| abstract |
[PROBLEMS] To provide a pharmaceutical composition useful as a preventive and / or therapeutic agent for gastric ulcer, duodenal ulcer, anastomotic ulcer, Zollinger-Ellison syndrome, reflux esophageal salt, acute and chronic gastritis, etc. . A pharmaceutical composition comprising a combination of roxatidine, which is an H 2 receptor antagonist, and a pharmaceutically acceptable salt thereof, and rebamipide, which is a protective factor potentiator, and has a normal dose or a small dose (low dose). A pharmaceutical composition that exhibits an excellent therapeutic effect even at a dose and can reduce side effects. [Selection figure] None |